The Cambridge-based firm, established in 2018, is a corporate venture capital arm of Yongjin Group and sister firm of Yonghua Capital. Yonjin Venture focuses on innovative technologies in therapeutics, diagnostics, and medical devices, with a specialization in early and mid-stage life science companies.